Side effects are generally mild and manageable, usually involving only mild gastrointestinal symptoms that resolve quickly
However, multivitamins have limitations for GLP-1 users specifically
Semaglutide (sold as Wegovy for weight loss) targets one receptor and produces about 15% loss
Although there is no known genetic link that increases the risk of acute pancreatitis while taking GLP-1 medicines, the MHRA said: Sometimes genes can influence the side-effects an individual experiences when taking a medicine, so in the context of the increasing usage of these medicines and the reports of acute pancreatitis we have received, we are exploring this further. Studies have shown that adverse reactions to medication account for one in six hospital admissions
A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity
Transdermal delivery works well for small, lipophilic (fat-soluble) molecules with specific molecular weights that can penetrate skin effectively